Background: Multiple sclerosis (MS) has a unique geographical distribution that reflects both genetic and environmental factors. Many studies have shown a positive correlation between MS frequency and latitude across both large and small geographical regions. However, scarce data have been published on the epidemiology of MS in Latin America and no study has evaluated latitudinal variation.
Objective: To evaluate the effect of latitude on MS prevalence in Latin America.
Methods: We conducted a systematic review of MS prevalence during January 2011. Prevalence rates were collected from eligible publications. The effect of latitude on prevalence was analyzed using linear regression.
Results: A total of ten studies were eligible for analysis, corresponding to six countries, spanning from Panama to Argentina. The crude prevalence of MS ranged from 0.75 to 21.5 per 100,000. We found a strong and significant association between prevalence and latitude (r2 0.8; p < 0.001) and determined an increase in prevalence of 0.33 per 100,000 per degree latitude.
Conclusion: Our findings suggest a latitudinal prevalence gradient of MS in Latin American countries between Panama and Argentina.
KurtzkeJF. A reassessment of the distribution of multiple sclerosis Part one. Acta Neurol Scand1975; 51: 110–136.
2.
CristianoEPatruccoLRojasJI. A systematic review of the epidemiology of multiple sclerosis in South America. Eur J Neurol2008; 15: 1273–1278.
3.
AlonsoAHernanMA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology2008; 71: 129–135.
4.
Koch-HenriksenNSorensenPS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol2010; 9: 520–532.
5.
McGuiganCMcCarthyAQuigleyCBannanLHawkinsSAHutchinsonM. Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity. J Neurol Neurosurg Psychiatry2004; 75: 572–576.
6.
VukusicSVan BockstaelVGosselinSConfavreuxC. Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiatry2007; 78: 707–709.
7.
CallegaroDde LolioCARadvanyJTilberyCPMendoncaRAMeloAC. Prevalence of multiple sclerosis in the city of Sao Paulo, Brazil, in 1990. Neuroepidemiology1992; 11: 11–14.
8.
MelconMOGoldLCarraACaceresFCorrealeJCristianoE. Argentine Patagonia: prevalence and clinical features of multiple sclerosis. Mult Scler2008; 14: 656–662.
9.
MelconMOVergaraRHCerattoR. Multiple sclerosis prevalence in Junín Argentina. Neuroepidemiology1992; 11: 11–14.
10.
GraciaFCastilloLCBenzadonALarreateguiMVillarealFTrianaE. Prevalence and incidence of multiple sclerosis in Panama (2000–2005). Neuroepidemiology2009; 32: 287–293.
11.
ToroJSarmientoOLDiaz del CastilloASatizabalCLRamirezJDMontenegroAC. Prevalence of multiple sclerosis in Bogota, Colombia. Neuroepidemiology2007; 28: 33–38.
12.
CristianoEPatruccoLRojasJICáceresFCarráACorrealeJ. Prevalence of multiple sclerosis in Buenos Aires, Argentina using the capture-recapture method. Eur J Neurol2009; 16: 183–187.
13.
DadaltiYPeresM. Prevalence of multiple sclerosis in the city of Santos, SP. Rev Bras Epidemiol2007; 10: 479–482.
14.
VizcarraDKawanoJCastañedaCCherequeATipismanaMBernabéA. Prevalencia de Esclerosis Múltiple en Lima – Peru. Revista Médica Herediana2009; 20: 146–150.
15.
SánchezJLAguirreCArcos-BurgosM. Prevalencia de la esclerosis múltiple en Colombia. Rev Neurol2000; 31: 1101–1103.
16.
CallegaroDGoldbaumMMoraisLTilberyCMoreiraMGabbaiA. The prevalence of multiple sclerosis in the city of Sao Paulo, Brazil, 1997. Acta Neurol Scand2001; 104: 208–213.
17.
AbadPPerezMCastroEAlarconTSantibanezRDiazF. Prevalence of multiple sclerosis in Ecuador. Neurologia2010; 25: 309–313.
18.
SumelahtiMLTienariPJWikstromJPaloJHakamaM. Increasing prevalence of multiple sclerosis in Finland. Acta Neurol Scand2001; 103: 153–158.
19.
LizcanoF. Composición Étnica de las Tres Áreas Culturadles del Continente Americano al Comienzo del Siglo XXI. Convergencia2005; 38: 185–232.
20.
van der MeiIAPonsonbyALBlizzardLDwyerT. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology2001; 20: 168–174.
21.
SlokaJSPryse-PhillipsWEStefanelliM. The relation of ultraviolet radiation and multiple sclerosis in Newfoundland. Can J Neurol Sci2008; 35: 69–74.
22.
BeretichBDBeretichTM. Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Mult Scler2009; 15: 891–898.
23.
MungerKLLevinLIHollisBWHowardNSAscherioA. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA2006; 296: 2832–2838.
24.
MungerKLZhangSMO'ReillyEHernanMAOlekMJWillettWC. Vitamin D intake and incidence of multiple sclerosis. Neurology2004; 62: 60–65.
25.
HolickMF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr2004; 80(6 Suppl): 1678S–1688S.
26.
CantornaMTHayesCEDeLucaHF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A1996; 93: 7861–7864.
27.
LucasRMPonsonbyAL. Considering the potential benefits as well as adverse effects of sun exposure: can all the potential benefits be provided by oral vitamin D supplementation?Prog Biophys Mol Biol2006; 92: 140–149.
28.
LeitenbergerJJacobeHTCruzPDJr. Photoimmunology—illuminating the immune system through photobiology. Semin Immunopathol2007; 29: 65–70.
29.
KurtzkeJF. On the fine structure of the distribution of multiple sclerosis. Acta Neurol Scand1967; 43: 257–282.
30.
ZivadinovRIonaLMonti-BragadinLBoscoAJurjevicATausC. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology2003; 22: 65–74.
